Who are Hyperion Therapeutics's investors?

Hyperion Therapeutics's investors include Bay City Capital, Sofinnova Ventures.

How much funding has Hyperion Therapeutics raised?

Hyperion Therapeutics has disclosed $8M raised across 1 round.

Hyperion Therapeutics is headquartered in Brisbane, US.

Brisbane, US · 2 known investors

Addressing unmet needs in gastroenterology and hepatology. (NASDAQ: HPTX) (Acquired Horizon Therapeutics)

Bo Jesper HansenNamed on SEC filing

Christine NashNamed on SEC filing

Natalie HollesNamed on SEC filing

Jake R. NunnNamed on SEC filing

Bijan SalehizadehNamed on SEC filing

Daniel G. WelchNamed on SEC filing

Ashley GouldNamed on SEC filing

Lota S. ZothNamed on SEC filing

Donald J. SantelNamed on SEC filing

Klara A. DickinsonNamed on SEC filing

Bruce F. ScharschmidtNamed on SEC filing

Jeffrey S. FarrowNamed on SEC filing

Form D private placements

$8M disclosed across 1 round · 2014

▶$8MraisedJun 2014 · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does Hyperion Therapeutics do?: Addressing unmet needs in gastroenterology and hepatology. (NASDAQ: HPTX) (Acquired Horizon Therapeutics)
Who are Hyperion Therapeutics's investors?: Hyperion Therapeutics's investors include Bay City Capital, Sofinnova Ventures.
How much funding has Hyperion Therapeutics raised?: Hyperion Therapeutics has disclosed $8M raised across 1 round.
Where is Hyperion Therapeutics headquartered?: Hyperion Therapeutics is headquartered in Brisbane, US.